NCT05106712 is a NA clinical trial of Vitamin D3 in Female Infertility, sponsored by Umm Al-Qura University.

Who is sponsoring NCT05106712?

NCT05106712 is sponsored by Umm Al-Qura University.

What drugs are being tested in NCT05106712?

Interventions in NCT05106712: Vitamin D3, Clomiphene Citrate, Letrozole, placebo.

What condition does NCT05106712 study?

NCT05106712 studies Female Infertility, Polycystic Ovary Syndrome, Pathologic Processes, Vitamin D Deficiency, IVF, Vitamin D Supplement.

Is NCT05106712 still recruiting?

NCT05106712 is currently status unknown. Last updated 4 November 2021.

Last reviewed 2021-11-04 · How we verify

NCT05106712

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women

Status unknown NA Last updated 4 November 2021

What this trial tests

NA trial testing Vitamin D3 in Female Infertility in 700 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
1 July 2023

1 November 2023

Quick facts

Lead sponsor	Umm Al-Qura University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	700
Start date	1 November 2021
Primary completion	1 July 2023
Estimated completion	1 November 2023

Drugs / interventions tested

Vitamin D3 (cholecalciferol) — full drug profile →
Clomiphene Citrate — full drug profile →
Letrozole — full drug profile →
placebo

Conditions studied

Female Infertility — all drugs for Female Infertility →
Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →
Pathologic Processes — all drugs for Pathologic Processes →
Vitamin D Deficiency — all drugs for Vitamin D Deficiency →

Sponsor

Umm Al-Qura University

Who can join

Adults 20 to 42, female only, with Female Infertility or Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized double-blinded-controlled clinical trial consists of two protocols as follow: protocol 1: evaluation of the therapeutic effects of Vitamin D3 supplement when given alone and in combination with an ovulation-inducing agent (e.g., Clomiphene citrate or Letrozole) on ovarian functional status and hormonal and metabolic features of PCOS-Vitamin D-deficient infertile Saudi women; and protocol 2: evaluation of the effectiveness of Vitamin D3 supplement versus placebo on the clinical pregnancy rate, fertilization implantation rate, live birth rate, and other outcome parameters following in-vitro fertilization (IVF) application in these PCOS-Vitamin D-deficient infertile patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin D3

Trials testing the same drug.

NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
NCT07460336 — Effects of Cofrogliptin on Beta-Cell Function in LADA Patients · NA · not yet recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting
NCT07269223 — Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients · NA · recruiting
NCT07048860 — ICOPE INTENSE-K Pilot Study · NA · recruiting

Other recruiting trials for Female Infertility

Currently open trials in the same condition.

NCT07500337 — Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes · NA · recruiting
NCT07394530 — Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS · NA · recruiting
NCT07066267 — Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) · NA · recruiting
NCT06896747 — Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study · Phase 1, PHASE2 · recruiting
NCT06921395 — Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulat · Phase 4 · recruiting

Other Umm Al-Qura University trials

Trials by the same sponsor.

NCT07322861 — Virtual Reality-Based vs Traditional Physiotherapy for Balance, Frailty, and Fall Prevention in Adults Aged 45 Years and · NA · not yet recruiting
NCT06735963 — Evaluating the Impact of a Meta Quest 3 Gamified VR Rehabilitation Program in Knee Osteoarthritis · NA · not yet recruiting
NCT07515417 — Effect of Magnesium Supplementation on Sleep Quality and Cognitive Function in Saudi Adults · NA · active not recruiting
NCT06974435 — Interval Training and Electromagnetic Therapy on Cardiovascular Disease Risk in Diabetic Elderly · NA · completed
NCT06974422 — Weight Off-loading Training, Cardiovascular Indices, Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05106712 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Umm Al-Qura University
Last refreshed: 4 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05106712.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing